Positive CTCs had higher sensitivity (87.5%) and specificity (92%) in predicting postoperative recurrence than CEA (60.4% and 83.2%, respectively), implying that the presence of CTCs was more powerful for predicting CRC recurrence than elevated CEA. This evidence concerns the gene CEACAM5 and colorectal carcinoma.